| Particulars |
|
|
|
| Company Name
| Zydus Lifesciences Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
100.62 |
B.V. (₹) |
235.30 |
| Sales(₹ Cr.) |
11,076.40 |
NP (₹ Cr.) |
3,692.43 |
| NP Var% |
-36.00 |
Div% |
100.00 |
| CPS(₹) |
42.30 |
EPS (₹) |
36.70 |
| Traded Value(₹ Lakhs) |
367.56 |
52 Week High |
1,115.00 |
| 52 Week Low |
836.00 |
Price BSE |
1,077.00 |
| Price NSE |
1,078.00 |
Market Capital (₹ Cr.) |
108,396.56 |
| P/C Ratio |
25.50 |
P/E Ratio |
29.30 |
| Price Vs.BV |
4.58 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
3,564.60 |
| NP(₹ Cr.) |
1,806.20 |
NP Var % |
-36.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
11,945.40 |
| OPM |
48.07 |
NP |
4,352.72 |
| NP Var% |
-35.59 |
EPS |
36.70 |
| PE |
29.35 |
|
|